FEXOFENADINE ZENTIVA 180 mg, film-coated tablet 15 tablets, CIP 3400934546068
Active ingredients: Fexofenadine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet15 tablets, CIP 3400934546068orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FEXOFENADINE ZENTIVA 180 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65337271CIP73454606CIP133400934546068Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE FEXOFÉNADINEcomprimé | 180,000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.